Fukuda Ryosuke
Research Areas 【 display / non-display 】
-
Research field:Life Science / Molecular biology
-
Research field:Life Science / Pharmaceutical hygiene and biochemistry
Papers 【 display / non-display 】
-
Language: English
Title: A Split-Luciferase-Based Trimer Formation Assay as a High-throughput Screening Platform for Therapeutics in Alport Syndrome.
Journal name: Cell Chemical Biology
Date of publication: 2018.05
Author(s): Kohei Omachi, Hirofumi KaiType of publication: Research paper (scientific journal)
Co-author classification: Multiple Authorship
-
Language: English
Title: STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.
Journal name: Nephrology Dialysis Transplantation
Date of publication: 2018.02
Author(s): Tsubasa Yokota, Hirofumi KaiType of publication: Research paper (scientific journal)
Co-author classification: Multiple Authorship
-
Language: English
Title: Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.
Journal name: Clinical and Experimental Nephrology
Date of publication: 2017.12
Author(s): Kohei Omachi, Hirofumi KaiType of publication: Research paper (scientific journal)
Co-author classification: Multiple Authorship
-
Language: English
Title: Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.
Journal name: Nature Communications
Date of publication: 2017.08
Author(s): Miklos Bagdany, Gergely L. LukacsType of publication: Research paper (scientific journal)
Co-author classification: Multiple Authorship
-
Language: English
Title: Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
Journal name: Journal of the American Society of Nephrology
Date of publication: 2016.01
Author(s): Hirofumi KaiType of publication: Research paper (scientific journal)
Co-author classification: Multiple Authorship